About
S4 Medical is a medical device company focused on improving patient safety during cardiac ablation procedures for atrial fibrillation (AF). Their flagship product, esolution®, is the first and only FDA-cleared device indicated for use with any ablation energy source to deviate the esophagus away from the ablation catheter, reducing the risk of ablation-related esophageal injury. The esophagus runs in close proximity to the ablation target area, and esophageal injury has been reported in up to 47% of AF ablation patients. esolution addresses this critical safety gap by applying vacuum suction to move the esophagus bilaterally—left or right—based on pulmonary vein anatomy and the electrophysiologist's lesion strategy. Designed specifically for catheter ablation workflows, esolution requires no unique hardware, software, or accessories. It is compatible with any ablation modality, supports 9Fr temperature probes, and does not interfere with existing mapping systems. Clinical data shows esolution delivers an 18% reduction in RF time, 9× fewer procedure stops due to temperature increases, and an 84% reduction in thermal injury. The device empowers electrophysiologists to ablate with confidence anywhere in the left atrium while maximizing patient safety and procedural efficiency.
Key Features
- Bilateral Esophageal Deviation: Provides vacuum-powered deviation of the esophagus left or right to accommodate any pulmonary vein anatomy or lesion strategy.
- Universal Ablation Compatibility: Works with any ablation energy modality (RF, cryo, pulsed field, etc.) without requiring additional hardware or software.
- Temperature Probe Compatible: Supports 9Fr temperature probes and does not interfere with existing electrophysiology mapping systems.
- Proven Injury Reduction: Clinical data demonstrates an 84% reduction in thermal esophageal injury, 9× fewer procedure stops, and 18% less RF time.
- FDA-Cleared Safety Indication: The only device with FDA clearance specifically indicated to reduce ablation-related esophageal injury across all energy sources.
Use Cases
- Protecting the esophagus from thermal injury during radiofrequency catheter ablation for atrial fibrillation
- Enabling electrophysiologists to perform complete left atrium ablation with fewer procedure interruptions
- Reducing complication rates and improving patient safety outcomes in high-volume EP labs
- Integrating esophageal protection into existing ablation workflows without adding new equipment or software
- Supporting clinical research and quality improvement initiatives around AF ablation safety metrics
Pros
- Only FDA-Cleared Solution: esolution is uniquely positioned as the sole FDA-cleared device for esophageal protection across all AF ablation energy types.
- Seamless Workflow Integration: Requires no special hardware, software, or accessories, making it easy to integrate into existing electrophysiology lab workflows.
- Significant Clinical Outcomes: Demonstrated 84% reduction in thermal injury and 9× fewer procedure interruptions, improving both safety and efficiency.
Cons
- Highly Specialized Use Case: The device is purpose-built for AF catheter ablation, limiting its applicability outside electrophysiology procedures.
- Limited Public Pricing Information: As a medical device sold to hospitals and EP labs, pricing and procurement details are not publicly available on the website.
Frequently Asked Questions
What is esolution® used for?
esolution® is an FDA-cleared medical device used during catheter ablation for atrial fibrillation. It deviates the esophagus away from the ablation catheter to reduce the risk of thermal esophageal injury.
Is esolution® compatible with all ablation energy sources?
Yes. esolution is designed to work with any ablation modality, including radiofrequency (RF), cryoablation, and pulsed field ablation, without requiring additional hardware or software.
How does esolution® protect the esophagus?
The device is placed in the esophagus and uses vacuum suction to deviate it bilaterally—left or right—moving it away from the ablation energy being applied at the pulmonary veins.
What clinical evidence supports esolution®?
Clinical data shows esolution delivers an 84% reduction in thermal injury, 9× fewer procedure stops due to temperature increases, and 18% less RF time compared to unprotected procedures.
Can esolution® be used with temperature monitoring probes?
Yes. esolution is compatible with standard 9Fr temperature probes and does not interfere with electrophysiology mapping systems.
